Literature DB >> 23737641

Rasayana drugs from the Ayurvedic system of medicine as possible radioprotective agents in cancer treatment.

Manjeshwar Shrinath Baliga1, Sharake Meera, Lalit Kumar Vaishnav, Suresh Rao, Princy Louis Palatty.   

Abstract

The use of ionizing radiation, which is the cornerstone of cancer treatment, is compromised by the radiosensitivity of normal tissues. A chemical that can give selective benefit to the normal cells against the deleterious effects of ionizing radiation has been a long-sought goal. However, most of the compounds studied have shown inadequate clinical application owing to their inherent toxicity, undesirable side effects, and high cost. Studies carried out in the past 2 decades have shown that some of the classical Indian Ayurvedic drugs (Amritaprasham, Ashwagandha Rasayana, Brahma Rasayana, Chyavanprasha, Narasimha Rasayana, and Triphala Churna) possess radioprotective effects. In the current review, an attempt is made to summarize the radioprotective observations of these Ayurvedic drugs and the mechanisms responsible for the radioprotective effects.

Entities:  

Keywords:  Ayurveda; Rasayana drugs; cancer; polyherbal preparations; radiation protection

Mesh:

Substances:

Year:  2013        PMID: 23737641     DOI: 10.1177/1534735413490233

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  4 in total

Review 1.  Withania somnifera: From prevention to treatment of cancer.

Authors:  Dushani L Palliyaguru; Shivendra V Singh; Thomas W Kensler
Journal:  Mol Nutr Food Res       Date:  2016-01-29       Impact factor: 5.914

Review 2.  Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges.

Authors:  Vivek P Chavda; Aayushi B Patel; Kavya J Mistry; Suresh F Suthar; Zhuo-Xun Wu; Zhe-Sheng Chen; Kaijian Hou
Journal:  Front Oncol       Date:  2022-03-29       Impact factor: 6.244

Review 3.  Therapeutic Uses of Triphala in Ayurvedic Medicine.

Authors:  Christine Tara Peterson; Kate Denniston; Deepak Chopra
Journal:  J Altern Complement Med       Date:  2017-07-11       Impact factor: 2.579

4.  Complete tumor regression with exclusive Ayurvedic rasayana regimen in high-grade diffuse large B-cell lymphoma: A case report.

Authors:  Yogesh Narayan Bendale; Avinash Kadam; Anandrao Patil; Poonam Kantilal Birari-Gawande
Journal:  Clin Case Rep       Date:  2022-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.